This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Orion Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovations of Anders Rudehill
Introduction
Anders Rudehill is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of severe health conditions. His work has garnered attention for its potential impact on patient care and treatment outcomes.
Latest Patents
Anders Rudehill holds a patent for a method for treating septic shock using Levosimendan, or (−)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile. This innovative treatment has been recognized for its usefulness in managing congestive heart failure and septic shock. He has 1 patent to his name, showcasing his dedication to advancing medical science.
Career Highlights
Rudehill is associated with Orion Corporation, a company known for its commitment to developing effective pharmaceutical solutions. His work at Orion has allowed him to focus on critical health issues, contributing to the company's reputation as a leader in the pharmaceutical industry.
Collaborations
Anders Rudehill has collaborated with esteemed colleagues, including Anders Oldner and Michael Wanecek. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Anders Rudehill's contributions to medical innovation, particularly in the treatment of septic shock, highlight his role as a significant inventor in the pharmaceutical field. His work continues to influence the development of effective treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile